• LAST PRICE
    16.7800
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    16.3700/ 1
  • Ask / Lots
    20.1800/ 4
  • Open / Previous Close
    0.0000 / 16.7800
  • Day Range
    ---
  • 52 Week Range
    Low 12.9500
    High 25.4700
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 16.9
TimeVolumeRCUS
09:32 ET506716.93
09:34 ET56916.9
09:41 ET124916.595
09:43 ET100416.6514
09:45 ET105016.825
09:50 ET190016.77
09:52 ET152416.72
09:54 ET60016.73
09:56 ET20016.79
10:03 ET20416.77
10:06 ET20016.89
10:08 ET10016.95
10:10 ET292516.86
10:12 ET121916.87
10:14 ET40016.87
10:15 ET41016.86
10:19 ET10016.87
10:26 ET174416.79
10:28 ET10016.825
10:32 ET30016.9
10:33 ET20016.88
10:35 ET31516.87
10:37 ET93016.855
10:48 ET15916.85
10:50 ET20016.845
10:53 ET48916.82
10:55 ET53116.82
11:00 ET70416.82
11:04 ET20016.86
11:06 ET14716.855
11:08 ET10016.85
11:09 ET140916.87
11:11 ET10016.92
11:13 ET40016.94
11:15 ET10016.91
11:18 ET30016.97
11:22 ET10016.97
11:26 ET164916.88
11:27 ET10016.93
11:29 ET10016.94
11:31 ET120416.93
11:33 ET97316.91
11:36 ET10016.95
11:38 ET10016.91
11:40 ET106616.9
11:42 ET42916.91
11:44 ET80616.96
11:45 ET161717.04
11:47 ET10017.05
11:49 ET103717.05
11:54 ET20017.05
11:58 ET10017.05
12:00 ET290417.05
12:02 ET93217.07
12:03 ET60017.1
12:07 ET120017.12
12:09 ET10017.09
12:12 ET80017.14
12:14 ET219617.11
12:16 ET118717.12
12:18 ET71917.1
12:20 ET80017.04
12:21 ET134116.98
12:23 ET13017.0393
12:25 ET40016.99
12:27 ET95117.02
12:30 ET20017.05
12:38 ET20017.07
12:39 ET190817.09
12:43 ET499417.03
12:45 ET10017.045
12:48 ET20017.08
12:50 ET20017.05
12:56 ET24617.065
12:57 ET40017.04
01:03 ET14717.07
01:06 ET50117.09
01:10 ET263717.08
01:12 ET122617.11
01:14 ET50517.11
01:15 ET35217.15
01:17 ET20017.18
01:19 ET81617.16
01:24 ET30017.14
01:28 ET210817.092
01:30 ET118517.106
01:32 ET22417.1
01:33 ET94517.1
01:35 ET108217.06
01:37 ET113017.05
01:42 ET110817.09
01:44 ET49417.1
01:46 ET10017.1
01:48 ET73017.07
01:50 ET10017.13
01:51 ET51117.13
01:53 ET90017.1
01:55 ET487017.065
01:57 ET194217.05
02:02 ET141517.03
02:04 ET174217.04
02:06 ET30017.03
02:08 ET73317.04
02:09 ET144117.03
02:11 ET20017.01
02:13 ET30017.01
02:15 ET150217
02:18 ET180917.02
02:26 ET20017
02:27 ET40017.04
02:29 ET138516.99
02:31 ET83216.97
02:33 ET601716.945
02:36 ET10016.93
02:38 ET34016.94
02:40 ET124216.92
02:42 ET371716.87
02:44 ET10016.87
02:45 ET20016.88
02:47 ET87216.86
02:51 ET10016.86
02:54 ET53216.87
02:56 ET98016.85
02:58 ET30016.86
03:00 ET70016.82
03:02 ET150616.83
03:03 ET10016.835
03:07 ET63216.83
03:09 ET375116.85
03:12 ET106516.855
03:14 ET10016.86
03:16 ET10316.86
03:18 ET20016.86
03:20 ET423916.84
03:21 ET10016.83
03:23 ET287616.81
03:25 ET545216.85
03:27 ET139116.84
03:30 ET442716.785
03:34 ET187116.77
03:36 ET461316.801
03:38 ET32716.8
03:39 ET190016.8
03:41 ET631416.79
03:43 ET179716.79
03:45 ET154616.775
03:48 ET571116.79
03:50 ET366016.78
03:52 ET416716.76
03:54 ET1028016.72
03:56 ET715116.69
03:57 ET1496116.69
03:59 ET13709216.78
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRCUS
Arcus Biosciences Inc
1.5B
-5.4x
---
United StatesGYRE
Gyre Therapeutics Inc
1.2B
-7.7x
---
United StatesARDX
Ardelyx Inc
1.9B
-27.5x
---
United StatesXNCR
Xencor Inc
1.5B
-10.8x
---
United StatesVIR
Vir Biotechnology Inc
1.3B
-2.4x
---
United StatesPRTA
Prothena Corporation PLC
1.2B
-7.0x
---
As of 2024-05-21

Company Information

Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.

Contact Information

Headquarters
3928 Point Eden WayHAYWARD, CA, United States 94545-3719
Phone
510-694-6200
Fax
302-730-1370

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Terry Rosen
President, Co-Founder
Juan Jaen
Chief Financial Officer
Robert Goeltz
Chief Operating Officer
Jennifer Jarrett
Chief Accounting Officer
Alexander Azoy

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.5B
Revenue (TTM)
$237.0M
Shares Outstanding
91.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.87
EPS
$-3.10
Book Value
$6.12
P/E Ratio
-5.4x
Price/Sales (TTM)
6.4
Price/Cash Flow (TTM)
---
Operating Margin
-113.92%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.